Chavez Ryan Daniel 4
4 · Asterias Biotherapeutics, Inc. · Filed Mar 30, 2018
Insider Transaction Report
Form 4
Chavez Ryan Daniel
Exec. VP of Fin & Gen. Counsel
Transactions
- Tax Payment
Common Stock
2018-03-30$1.45/sh−6,483$9,400→ 175,157 total
Holdings
- 380,000
Stock Option
Exercise: $2.91Exp: 2026-07-17→ Common Stock (380,000 underlying) - 150,000
Stock Options
Exercise: $1.95Exp: 2028-03-14→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported.
- [F2]Subject to Mr. Chavez's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was March 14, 2018. The stock options are exercisable upon vesting.
- [F3]Subject to Mr. Chavez's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was July 18, 2016. The stock options are exercisable upon vesting.